Congruence Therapeutics, a pioneering biotechnology company focused on developing novel small molecule correctors, has successfully closed a significant $39.5 million…
Read More
Vitestro Secures $70 Million Series B Funding to Revolutionize Blood Collection with Autonomous Robotics
Vitestro, a pioneering Dutch medical technology firm, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…
Read More
